Weather
The Pine Tree, News for Calaveras County and Beyond Weather
Amador Angels Camp Arnold Bear Valley Copperopolis Murphys San Andreas Valley Springs Moke Hill/West Point Tuolumne
News
Business Directory
Weather & Roads
Sports
Real Estate
Search
Weekly & Grocery Ads
Entertainment
Life & Style
Government
Law Enforcement
Business
Wine News
Health & Fitness
Home & Garden
Food & Dining
Religion & Faith
Frogtown USA
Legal Notices
Calendar
Polls
Columns
Free Classifieds
Letters to the Editor
Obituaries
About Us

Coming Soon...
Wednesday, Oct 17
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Thursday, Oct 18
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Friday, Oct 19
08:00 AM Rummage to the Rescue
08:00 AM Rummage to the Rescue!
09:00 AM Quilt Show
09:00 AM Mountain Heirloom Quilt Faire
09:00 AM Quilt Show
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
05:30 PM Friday Night Music at Alchemy
Saturday, Oct 20
All Day Quilt Show
All Day Mountain Heirloom Quilt Faire
All Day Quilt Show
10:00 AM Old Timers Museum Walking Tours Are Every Saturday at 10am.
11:00 AM Guided Tours of Ironstone Vineyards
11:00 AM Town Tours of Columbia State Historic Park
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
04:00 PM Harvest Happy Hour with Milliaire
Sunday, Oct 21
12:00 AM Before I Die Forum is Sunday, October 21st from 1 - 5pm in San Andreas
07:30 AM All You Can Eat Pancake Breakfast by Native Sons of the Golden West
Until 04:00 PM Quilt Show
Until 04:00 PM Mountain Heirloom Quilt Faire
Until 04:00 PM Quilt Show
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Monday, Oct 22
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Tuesday, Oct 23
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Wednesday, Oct 24
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Thursday, Oct 25
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Friday, Oct 26
11:00 AM Guided Tours of Ironstone Vineyards
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
05:30 PM Friday Night Music at Alchemy
Saturday, Oct 27
10:00 AM Old Timers Museum Walking Tours Are Every Saturday at 10am.
11:00 AM Guided Tours of Ironstone Vineyards
11:00 AM Town Tours of Columbia State Historic Park
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
04:00 PM Harvest Happy Hour with Milliaire
Sunday, Oct 28
11:00 AM Sunday Funday at Ironstone Vineyards
11:00 AM Guided Tours of Ironstone Vineyards
11:00 AM Town Tours of Columbia State Historic Park
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Monday, Oct 29
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group
Tuesday, Oct 30
All Day Calaveras/Amador County Autism/Aspergers Peer Support Group

Search Announcements




Log In
Username

Password

Remember Me



Posted by: thepinetree on 04/12/2018 08:57 AM Updated by: thepinetree on 04/12/2018 08:57 AM
Expires: 01/01/2023 12:00 AM
:

FDA Approves Marketing of AI Based Device to Detect Diabetes-Related Eye Problems

Washington, DC...The U.S. Food and Drug Administration is permitting marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye. Diabetic retinopathy is the most common cause of vision loss among the more than 30 million Americans living with diabetes and the leading cause of vision impairment and blindness among working-age adults.




“Early detection of retinopathy is an important part of managing care for the millions of people with diabetes, yet many patients with diabetes are not adequately screened for diabetic retinopathy since about 50 percent of them do not see their eye doctor on a yearly basis,” said Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat Devices at the FDA's Center for Devices and Radiological Health. “Today’s decision permits the marketing of a novel artificial intelligence technology that can be used in a primary care doctor’s office. The FDA will continue to facilitate the availability of safe and effective digital health devices that may improve patient access to needed health care.”

The device, called IDx-DR, is a software program that uses an artificial intelligence algorithm to analyze images of the eye taken with a retinal camera called the Topcon NW400. A doctor uploads the digital images of the patient’s retinas to a cloud server on which IDx-DR software is installed. If the images are of sufficient quality, the software provides the doctor with one of two results: (1) “more than mild diabetic retinopathy detected: refer to an eye care professional” or (2) “negative for more than mild diabetic retinopathy; rescreen in 12 months.” If a positive result is detected, patients should see an eye care provider for further diagnostic evaluation and possible treatment as soon as possible.

IDx-DR is the first device authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results, which makes it usable by health care providers who may not normally be involved in eye care.

The FDA evaluated data from a clinical study of retinal images obtained from 900 patients with diabetes at 10 primary care sites. The study was designed to evaluate how often IDx-DR could accurately detect patients with more than mild diabetic retinopathy. In the study, IDx-DR was able to correctly identify the presence of more than mild diabetic retinopathy 87.4 percent of the time and was able to correctly identify those patients who did not have more than mild diabetic retinopathy 89.5 percent of the time.

Patients who have a history of laser treatment, surgery or injections in the eye or who have any of the following conditions should not be screened for diabetic retinopathy with IDx-DR: persistent vision loss, blurred vision, floaters, previously diagnosed macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy or retinal vein occlusion. IDx-DR should not be used in patients with diabetes who are pregnant; diabetic retinopathy can progress very rapidly during pregnancy and IDx-DR is not intended to evaluate rapidly progressive diabetic retinopathy. IDx-DR is only designed to detect diabetic retinopathy, including macular edema; it should not be used to detect any other disease or condition. Patients will still need to get a complete eye examination at the age of 40 and at the age of 60 and also if they have any vision symptoms (for example, persistent vision loss, blurred vision or floaters).

IDx-DR was reviewed under the FDA’s De Novo premarket review pathway, a regulatory pathway for some low- to moderate-risk devices that are novel and for which there is no prior legally marketed device. IDx-DR was granted Breakthrough Device designation, meaning the FDA provided intensive interaction and guidance to the company on efficient device development, to expedite evidence generation and the agency’s review of the device. To qualify for such designation, a device must provide for more effective treatment or diagnosis of a life-threatening or irreversibly debilitating disease or condition, and meet one of the following criteria: the device must represent a breakthrough technology; there must be no approved or cleared alternatives; the device must offer significant advantages over existing approved or cleared alternatives; or the availability of the device is in the best interest of patients.

The FDA is permitting marketing of IDx-DR to IDx LLC.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###


Comments - Make a comment
The comments are owned by the poster. We are not responsible for its content. We value free speech but remember this is a public forum and we hope that people would use common sense and decency. If you see an offensive comment please email us at news@thepinetree.net
No Subject
Posted on: 2018-04-12 13:17:41   By: Anonymous
 
The USDA Goes "weee@$%^&?+&" boom!

[Reply ]


What's Related
These might interest you as well
Local News

Calendar

phpws Business Directory

Photo Albums

RSS News Feeds

Web Pages


Mark Twain Medical Center
Meadowmont Pharmacy
Bank of Stockton
Bear Valley Real Estate
Bear Valley Cross Country
Cedar Creek Realty
Cave, Mine & Zip Lines
Fox Security
Bistro Espresso
Pinnacle Physical Therapy
Chatom Winery
Middleton's Furniture
Bear Valley Mountain Resort
Paul D. Bertini
Premier Properties
High Country Spa & Stove
Sierra Logging Museum
Calaveras Mentoriing

Ebbetts Pass Scenic Byway
Sierra Logging Museum
Jenny's Kitchen

Copyright © The Pine Tree 2005-2018